IMCT-01 PEMBROLIZUMAB: FIRST EXPERIENCE WITH RECURRENT PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

Por Blumenthal, Deborah T., Yalon, Michal, Bokstein, Felix
Publicado no Neuro Oncol (2015)

High metallothionein predicts poor survival in glioblastoma multiforme

Por Mehrian-Shai, Ruty, Yalon, Michal, Simon, Amos J., Eyal, Eran, Pismenyuk, Tatyana, Moshe, Itai, Constantini, Shlomi, Toren, Amos
Publicado no BMC Med Genomics (2015)

CB-02 MiRNA EXPRESSION PROFILES OF GLIOMA STEM CELLS AND THEIR ASSOCIATION WITH THE MESENCHYMAL TRANSFORMATION OF THESE CELLS

Por Bier, Ariel, Finniss, Susan, Cazacu, Simona, Xiang, Cunli, Lee, Hae Kyung, Rand, Daniel, Yalon, Michal, Toren, Amos, Poisson, Laila, Brodie, Chaya
Publicado em 2014

Identification of genomic aberrations in hemangioblastoma by droplet digital PCR and SNP microarray highlights novel candidate genes and pathways for pathogenesis

Por Mehrian-Shai, Ruty, Yalon, Michal, Moshe, Itai, Barshack, Iris, Nass, Dvorah, Jacob, Jasmine, Dor, Chen, Reichardt, Juergen K. V., Constantini, Shlomi, Toren, Amos
Publicado no BMC Genomics (2016)

HG-02 A PHASE 1/2 TRIAL OF THE ANTIBODY PIDILIZUMAB (MDV9300) IN PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA

Por Fried, Iris, Lossos, Alex, BenAmi, Tal, Dvir, Rina, Toledano, Helen, Ben Arush, Myriam, Postovski, Sergei, AbuKuidar, Abed, Yalon, Michal, Weintraub, Michael
Publicado no Neuro Oncol (2016)

Related to testes-specific, vespid and pathogenesis protein-1 is regulated by methylation in glioblastoma

Por JACOBY, ELAD, YALON, MICHAL, LEITNER, MOSHE, COHEN, ZVI R., COHEN, YEHUDIT, FISHER, TAMAR, EDER, SARIT, AMARIGLIO, NINETTE, RECHAVI, GIDEON, CAZACU, SIMONA, XIANG, CUNLI, MIKKELSEN, TOM, BRODIE, CHAYA, TOREN, AMOS
Publicado em 2014

MicroRNA-145 Is Downregulated in Glial Tumors and Regulates Glioma Cell Migration by Targeting Connective Tissue Growth Factor

Por Lee, Hae Kyung, Bier, Ariel, Cazacu, Simona, Finniss, Susan, Xiang, Cunli, Twito, Hodaya, Poisson, Laila M., Mikkelsen, Tom, Slavin, Shimon, Jacoby, Elad, Yalon, Michal, Toren, Amos, Rempel, Sandra A., Brodie, Chaya
Publicado em 2013

MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1

Por Bier, Ariel, Giladi, Nis, Kronfeld, Noam, Lee, Hae Kyung, Cazacu, Simona, Finniss, Susan, Xiang, Cunli, Poisson, Laila, deCarvalho, Ana C., Slavin, Shimon, Jacoby, Elad, Yalon, Michal, Toren, Amos, Mikkelsen, Tom, Brodie, Chaya
Publicado em 2013

Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems

Por Toren, Amos, Pismenyuk, Tatyana, Yalon, Michal, Freedman, Shani, Simon, Amos J., Fisher, Tamar, Moshe, Itai, Reichardt, Juergen K.V., Constantini, Shlomi, Mardor, Yael, Last, David, Guez, David, Daniels, Dianne, Assoulin, Moria, Mehrian-Shai, Ruty
Publicado no Oncotarget (2016)

Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations

Por Yalon, Michal, Tuval-Kochen, Liron, Castel, David, Moshe, Itai, Mazal, Inbal, Cohen, Osher, Avivi, Camila, Rosenblatt, Kineret, Aviel-Ronen, Sarit, Schiby, Ginette, Yahalom, Joachim, Amariglio, Ninette, Pfeffer, Raphael, Lawrence, Yaacov, Toren, Amos, Rechavi, Gideon, Paglin, Shoshana
Publicado no PLoS One (2016)

Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations

Por Yalon, Michal, Tuval-Kochen, Liron, Castel, David, Moshe, Itai, Mazal, Inbal, Cohen, Osher, Avivi, Camila, Rosenblatt, Kineret, Aviel-Ronen, Sarit, Schiby, Ginette, Yahalom, Joachim, Amariglio, Ninette, Pfeffer, Raphael, Lawrence, Yaacov R., Toren, Amos, Rechavi, Gideon, Paglin, Shoshana
Publicado no PLoS One (2016)

Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma

Por Bartels, Ute, Wolff, Johannes, Gore, Lia, Dunkel, Ira, Gilheeney, Stephen, Allen, Jeffrey, Goldman, Stewart, Yalon, Michal, Packer, Roger J., Korones, David N., Smith, Amy, Cohen, Kenneth, Kuttesch, John, Strother, Douglas, Baruchel, Sylvain, Gammon, Janet, Kowalski, Mark, Bouffet, Eric
Publicado em 2014

NI-85 DELAYED CONTRAST MRI FOR DIFFERENTIATING TUMOR/NON-TUMOR TISSUES IN BRAIN TUMOR PATIENTS - HISTOLOGICAL VALIDATION AND COMPARISON WITH DSC/DCE

Por Zach, Leor, Last, David, Guez, David, Daniels, Dianne, Grober, Yuval, Nissim, Ouzi, Hoffmann, Chen, Nass, Dvora, Talianski, Alisa, Spiegelmann, Roberto, Salomon, Sharona, Kanner, Andrew, Blumenthal, Debora, Bukshtein, Felix, Yalon, Michal, Zauberman, Jacob, Limon, Dror, Tzuk, Tzahala, Cohen, Zvi, Mardor, Yael
Publicado em 2014

Delayed contrast extravasation MRI: a new paradigm in neuro-oncology

Por Zach, Leor, Guez, David, Last, David, Daniels, Dianne, Grober, Yuval, Nissim, Ouzi, Hoffmann, Chen, Nass, Dvora, Talianski, Alisa, Spiegelmann, Roberto, Tsarfaty, Galia, Salomon, Sharona, Hadani, Moshe, Kanner, Andrew, Blumenthal, Deborah T., Bukstein, Felix, Yalon, Michal, Zauberman, Jacob, Roth, Jonathan, Shoshan, Yigal, Fridman, Evgeniya, Wygoda, Marc, Limon, Dror, Tzuk, Tzahala, Cohen, Zvi R., Mardor, Yael
Publicado no Neuro Oncol (2015)

HG-53 HYPERMUTATION AND NEOANTIGEN FORMATION PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT GLIOBLASTOMA

Por Campbell, Brittany, Bouffet, Eric, Larouche, Valerie, Mason, Gary, Reddy, Alyssa, Osborn, Michael, Magimairan, Vanan, Merico, Daniele, de Borja, Richard, Chung, Brian, Galati, Melissa, Aronson, Melyssa, Durno, Carol, Kruger, Joerg, Cabric, Vanja, Zhukova, Nataliya, Ramaswamy, Vijay, Farah, Roula, Afzal, Samina, Yalon, Michal, Rechavi, Gideon, Walsh, Michael F., Constantini, Shlomi, Dvir, Rina, Elhasid, Ronit, Sullivan, Michael, Hansford, Jordan R., Dodgshun, Andrew, Klauber-Demore, Nancy, Peterson, Lindsay, Patel, Sunil, Lindhorst, Scott, Atkinson, Jeffrey, Laframboise, Rachel, Cohen, Zane, Dirks, Peter, Taylor, Michael, Malkin, David, Albrecht, Steffen, Dudley, Roy, Jabado, Nada, Hawkins, Cynthia, Shlien, Adam, Tabori, Uri
Publicado no Neuro Oncol (2016)